BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Retinaldehyde

A diterpene derived from the carotenoid VITAMIN A which functions as the active component of the visual cycle. It is the prosthetic group of RHODOPSIN (i.e., covalently bonded to ROD OPSIN as 11-cis-retinal). When stimulated by visible light, rhodopsin transforms this cis-isomer of retinal to the trans-isomer (11-trans-retinal). This transformation straightens-out the bend of the retinal molecule and causes a change in the shape of rhodopsin triggering the visual process. A series of energy-requiring enzyme-catalyzed reactions convert the 11-trans-retinal back to the cis-isomer.

300+ PubMed studies analyzed · 12 RCTs · Evidence Score: 42.8

Research Domains

Retinaldehyde has been studied across 17 research domains including 👁️ Vision & Eye, ✨ Skin & Hair, ⏳ Longevity & Aging, 🔥 Metabolic, ⚡ Energy & Fatigue. The primary research focus is 👁️ Vision & Eye with 74% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Retinaldehyde, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Toxaphene
21 shared targets
Potassium
14 shared targets
Vitamin
21 shared targets
o-Phthalaldehyde
17 shared targets
Spironolactone
18 shared targets
Dihydrotestosterone
19 shared targets
Methylcholanthrene
14 shared targets
Aprepitant
17 shared targets
Acetaldehyde
13 shared targets
Lynestrenol
16 shared targets
Loading evidence profile...

This evidence profile for Retinaldehyde is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.